Costs of Testing for Ocular Chlamydia trachomatis Infection Compared to Mass Drug Administration for Trachoma in The Gambia: Application of Results from the PRET Study

• Emma Harding-Esch,

  Affiliations London School of Hygiene and Tropical Medicine, London, United Kingdom, Public Health England, HIV/STI Department, London, United Kingdom

  ⨯
• Mireia Jofre-Bonet,

  Affiliation Department of Economics, City University, London, United Kingdom

  ⨯
• Jaskiran K. Dhanjal,

  Affiliation Abacus International, Bicester, Oxfordshire, United Kingdom

  ⨯
• Sarah Burr,

  Affiliation MRC Laboratories, Fajara, The Gambia

  ⨯
• Tansy Edwards,

  Affiliation London School of Hygiene and Tropical Medicine, London, United Kingdom

  ⨯
• Martin Holland,

  Affiliation London School of Hygiene and Tropical Medicine, London, United Kingdom

  ⨯
• Ansumana Sillah,

  Affiliation National Eye Health Programme, Banjul, The Gambia

  ⨯
• Sheila West,

  Affiliation Dana Center for Preventive Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• Tom Lietman,

  Affiliation The Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• Jeremy Keenan,

  Affiliation The Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• David Mabey,

  Affiliation London School of Hygiene and Tropical Medicine, London, United Kingdom

  ⨯
• Robin Bailey

  * E-mail: Robin.Bailey@lshtm.ac.uk

  Affiliation London School of Hygiene and Tropical Medicine, London, United Kingdom

  ⨯